跳轉至內容
Merck

1.05040

SAFC

碘化钾

EMPROVE® API, Ph. Eur., BP, ChP, JP, USP

製藥生產

登入查看組織和合約定價


About This Item

線性公式:
KI
CAS號碼:
分子量::
166.00
MDL號碼:
分類程式碼代碼:
12352302
酶委員會索引編號:
231-659-4

agency

BP
ChP
JP
Ph. Eur.
USP

品質等級

蒸汽壓力

1 mmHg ( 745 °C)

產品線

EMPROVE® API

形狀

solid

效力

2779 mg/kg LD50, oral (Rat)

pH值

6.9 (20 °C, 50 g/L in H2O)

bp

1325 °C/1013 hPa

mp

681 °C (lit.)

體積密度

1500 kg/m3

應用

liquid formulation
pharmaceutical
semi-solid formulation
solid formulation

儲存溫度

2-25°C

SMILES 字串

[K+].[I-]

InChI

1S/HI.K/h1H;/q;+1/p-1

InChI 密鑰

NLKNQRATVPKPDG-UHFFFAOYSA-M

尋找類似的產品? 前往 產品比較指南

相關類別

一般說明

We provide industry-leading production know-how and comprehensive regulatory support for high-quality APIs, backed by nearly 200 years of experience. From a complete portfolio of innovative folates to custom synthesis, our customized and scalable solutions meet your specific production needs. As part of our EMPROVE® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

應用

Potassium iodide is used in medicine to treat thyroid subfunction, as a trace element for iodide source in clinical nutrition and in dietary supplements. Potassium iodide Emprove® API is manufactured according to ICH Q7 guidelines. A CEP and US-DMF are available.

法律資訊

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

象形圖

Health hazard

訊號詞

Danger

危險聲明

危險分類

STOT RE 1 Oral

標靶器官

Thyroid

儲存類別代碼

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

水污染物質分類(WGK)

WGK 3


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

文章

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

與成人相比,兒童用藥面臨獨特的配方挑戰。在設計藥品時,請考慮兒童的發育生理和年齡特徵。品質問題會嚴重影響病患安全。因此,輔料品質、供應商選擇和供應鏈安全是至關重要的,特別是對於兒科配方。

相關內容

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務